iANTHUS CAPITAL HOLDINGS (ITHUF) Other Operating Expenses (2021 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Other Operating Expenses came in at $3.9 million in Q1 2026, down 4.37% year-on-year from $4.1 million in Q1 2025, and down 31.14% quarter-over-quarter from $5.7 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Other Operating Expenses (2021 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Other Operating Expenses across 6 years of filings, most recently posting $3.9 million for Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $3.9 million, down 4.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.0 million (up 4.24% YoY), and the FY2025 annual result was $13.2 million, up 4.61% from the prior year.
- Other Operating Expenses came in at $3.9 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from $5.7 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $36.7 million in Q4 2022 to a low of -$12000.0 in Q1 2022.
- The 5-year median for Other Operating Expenses is $5.7 million (2025), against an average of $6.8 million.
- Across the five-year window, Other Operating Expenses tumbled 100.17% in 2022 and jumped 4400.0% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Other Operating Expenses stood at $36.7 million in 2022, then plunged by 83.09% to $6.2 million in 2023, then slipped by 11.94% to $5.5 million in 2024, then grew by 3.46% to $5.7 million in 2025, then slumped by 31.14% to $3.9 million in 2026.
- The last three Other Operating Expenses figures came in at $3.9 million (Q1 2026), $5.7 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.89 Mn |
| Dec 31, 2025 | 5.65 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Mar 31, 2025 | 4.07 Mn |
| Dec 31, 2024 | 5.46 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 6.01 Mn |
| Mar 31, 2024 | 6.28 Mn |
| Dec 31, 2023 | 6.20 Mn |
| Sep 30, 2023 | 6.06 Mn |
| Jun 30, 2023 | 6.30 Mn |
| Mar 31, 2023 | 516,000.00 |
| Dec 31, 2022 | 36.69 Mn |
| Sep 30, 2022 | 6.69 Mn |
| Jun 30, 2022 | 6.96 Mn |
| Mar 31, 2022 | -12,000.00 |
| Dec 31, 2021 | 12.63 Mn |
| Sep 30, 2021 | 7.73 Mn |
| Jun 30, 2021 | 8.89 Mn |